Schedule 13G ownership disclosure
Phathom Pharmaceuticals Inc
Security class unavailable · CUSIP: 71722W107
Event date: 2024-01-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-016691
- Form type
- SC 13G
- Filer
- Medicxi Growth I LP
- CIK
- CIK 1690310
- Filed
- Jan 26, 2024
- Reporting period
- Jan 24, 2024
- Description
- Schedule 13G beneficial ownership